» Articles » PMID: 23872151

MicroRNA-340 Suppresses Osteosarcoma Tumor Growth and Metastasis by Directly Targeting ROCK1

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2013 Jul 23
PMID 23872151
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) play key roles in cancer development and progression. In the present study, we investigated the role of miR-340 in the progression and metastasis of osteosarcoma (OS). Our results showed that miR-340 was frequently downregulated in OS tumors and cell lines. Overexpression of miR-340 in OS cell lines significantly inhibited cell proliferation, migration, and invasion in vitro, and tumor growth and metastasis in a xenograft mouse model. ROCK1 was identified as a target of miR-340, and ectopic expression of miR-340 downregulated ROCK1 by direct binding to its 3' untranslated region. siRNA-mediated silencing of ROCK1 phenocopied the effects of miR-340 overexpression, whereas restoration of ROCK1 in miR-340-overexpressing OS cells reversed the suppressive effects of miR-340. Together, these findings indicate that miR-340 acts as a tumor suppressor and its downregulation in tumor tissues may contribute to the progression and metastasis of OS through a mechanism involving ROCK1, suggesting miR-340 as a potential new diagnostic and therapeutic target for the treatment of OS.

Citing Articles

Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.

Bassot A, Dragic H, Haddad S, Moindrot L, Odouard S, Corlazzoli F Cell Death Dis. 2023; 14(9):630.

PMID: 37749143 PMC: 10519979. DOI: 10.1038/s41419-023-06117-z.


Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis.

Todosenko N, Khlusov I, Yurova K, Khaziakhmatova O, Litvinova L Int J Mol Sci. 2023; 24(10).

PMID: 37240338 PMC: 10219319. DOI: 10.3390/ijms24108993.


MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas.

Teo A, Lim V, Yang V Cancers (Basel). 2023; 15(3).

PMID: 36765536 PMC: 9913386. DOI: 10.3390/cancers15030577.


Origin and Therapies of Osteosarcoma.

Moukengue B, Lallier M, Marchandet L, Baudhuin M, Verrecchia F, Ory B Cancers (Basel). 2022; 14(14).

PMID: 35884563 PMC: 9322921. DOI: 10.3390/cancers14143503.


miR-340: A multifunctional role in human malignant diseases.

Huang Z, Xu Y, Wan M, Zeng X, Wu J Int J Biol Sci. 2021; 17(1):236-246.

PMID: 33390846 PMC: 7757049. DOI: 10.7150/ijbs.51123.